News Patent of the Week: A Universal Microfluidic Culture System Microfluidic chips are useful in several applications, such as drug discovery, because of their ability to automatically replicate various cellular environments. As opposed to traditional dish-and-pipette techniques – which can...
News Patent of the Week: Increased Safety and Improved Protection of Vaccines Researchers, including Aaron Esser-Kahn, an associate professor at UChicago’s Pritzker School of Molecular Engineering, have filed a patent application for a novel additive that limits undesirable vaccine-related side effects. Many...
Technology New Platform For Targeted Immunomodulation And Vaccine Development There have been significant research efforts to develop effective vaccines that elicit a strong and durable T cell response against intracellular pathogens and cancer. A popular strategy has been to…
Technology Lymphangiogenesis For Therapeutic Immunomodulation A vaccine platform that uses engineered lymphangiogenesis factors and antigens to stimulate lymphatic endothelial cells, creating strong, long-lasting immune memory or tolerance with fewer side effects than traditional vaccines The…
Technology Tumor-Specific Cancer Vaccine Adjuvant Formulation Many cancer vaccines fail due to insufficient CD8+ T cell targeting. To save patient lives, oncologists need tumor-specific vaccines that increase CD8+ T cell response. The inventors developed and validated…
News Glowing Success Imagine you know nothing about basketball and have to figure out how the game works based on a few random snapshots. Depending on the snapshots you happen to have, it...
Technology RNA Editing Technology for Enhancing Tumor Immunogenicity and Immune Checkpoint Inhibitors Novel RNA editing method to generate a multitude of neoantigens in tumor cells making the cells more recognizable by T cells and enhancing the efficacy of immune checkpoint inhibitors The…
Technology A Highly-Efficient Platform To Form Vesicular Polymer Nanoparticles For RNA And Protein Payload Delivery Polymersomes are a type of nanoscale vesicle made from block copolymers and can encapsulate a variety of therapeutic agents including proteins and nucleic acids. These nanovesicles are assembled at room…
News Getting a Grip “Fundamental research is what keeps me up late at night,” says Heinrich Jaeger, PhD, the William J. Friedman and Alicia Townsend Professor of Physics at the University of Chicago. One...
Technology Diagnostic Assays And Engineered Compositions For Detecting Angiotensin II Autoantibodies And Preventing Coronavirus Autoimmunity Detection and monitoring of autoantibodies against Angiotensin II in COVID-19 patients, guiding diagnosis, treatment, and vaccine design to reduce blood pressure complications and prevent harmful autoimmune responses linked to the…
Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
News Life Sciences Community Convenes at Chicago BioCapital Summit in a Showcase of Local Innovation Hosted by the Chicago Biomedical Consortium (CBC), the inaugural Chicago BioCapital Summit this week brought together industry, academia, and investors in a showcase of the latest innovations in the life...
